Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
REPL
REPL News & Events
-
Add to Watchlist
Trade REPL
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
REPL News
Pomerantz LLP Investigates Replimune for Securities Fraud
1d ago
Globenewswire
REPL Faces Pressure After FDA Issues Second Complete Response Letter
Apr 14 2026
stocktwits
Replimune Faces FDA CRL for RP1 Melanoma Therapy Amid Analyst Downgrades
Apr 13 2026
Newsfilter
Replimune Shares Hit All-Time Low After FDA Rejection
Apr 13 2026
seekingalpha
Trump Threatens 50% Tariff on China Amid Trade Tensions
Apr 13 2026
Fool
Replimune's RP-1 Faces Second FDA Rejection, Shares Plunge
Apr 13 2026
stocktwits
U.S. Stock Futures Drop as Oil Prices Surge Above $100 Amid Iran Tensions
Apr 13 2026
seekingalpha
Replimune Shares Plunge 56% After FDA Rejects RP1 Approval
Apr 13 2026
seekingalpha
Show More News
REPL Events
No data
REPL Monitor News
Replimune's Stock Plummets After FDA Rejects RP1 Approval
Apr 13 2026
REPL Earnings Analysis
No Data
People Also Watch
